Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treamid for Post-COVID Lung Fibrosis
NCT04527354Phase 2Completed
- Sponsor
- PHARMENTERPRISES LLC
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of treamid in pulmonary fibrosis (PF), post-COVID-19 condition (PCC), sponsored by PHARMENTERPRISES LLC. Started Sep 2020; status: completed.
02
Drugs
treamid
03
Conditions
pulmonary fibrosis (PF)post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT04527354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527354.